Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail
Author:
Affiliation:
1. “G. Marconi” Chair of Dermatology and Venereology; University of Rome; Rome; Italy
2. Division of Dermatology, Department of Critical Care Medicine and Surgery; University of Florence; Florence; Italy
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1529-8019.2012.01465.x/fullpdf
Reference5 articles.
1. Clinical spectrum and severity of psoriasis;Meier;Curr Probl Dermatol,2009
2. How and when to use biologics in psoriasis;Kircik;J Drugs Dermatol,2010
3. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives;Yeilding;Ann N Y Acad Sci,2011
4. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial;Gottlieb;Lancet,2009
5. Ustekinumab: when everything else fails?;Vitiello;Int J Dermatol,2011
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice;JEADV Clinical Practice;2024-02-17
2. Biological treatment for erythrodermic psoriasis;Expert Opinion on Biological Therapy;2022-09-28
3. Sub-Erythroderma in a 52 Year Old Man;Clinical Cases in Exfoliative Dermatitis;2022
4. Updates on the Treatment of Erythrodermic Psoriasis;Psoriasis: Targets and Therapy;2021-06
5. Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab;Dermatologic Therapy;2020-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3